Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous Single and Repeated Doses of SAR441344 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 8, 2018

Primary Completion Date

April 10, 2020

Study Completion Date

April 10, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

SAR441344

Solution for intravenous/subcutaneous injection

DRUG

placebo

Solution for intravenous/subcutaneous injection

BIOLOGICAL

Keyhole limpet hemocyanin

Subcutaneous Lyophilized powder for reconstitution

Trial Locations (1)

PPD-Site Number:8400001, Austin